Literature DB >> 16051141

Decoding dopamine signaling.

James A Bibb1.   

Abstract

Dopamine is a key neurotransmitter that is important for many physiological functions including motor control, mood, and the reward pathway. In this issue of Cell, the laboratories of Marc Caron and Li-Huei Tsai identify two very different molecules--beta-arrestin 2 and Par-4, respectively--that unexpectedly are involved in dopamine signaling via the D2 receptor. These two new signaling pathways mediate the actions of dopamine on behavior and facilitate crosstalk between different signaling pathways that are activated by binding of dopamine to the D2 receptor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16051141     DOI: 10.1016/j.cell.2005.07.011

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  20 in total

1.  Inhibition of the dopamine D1 receptor signaling by PSD-95.

Authors:  Jingping Zhang; Angel Vinuela; Mark H Neely; Penelope J Hallett; Seth G N Grant; Gregory M Miller; Ole Isacson; Marc G Caron; Wei-Dong Yao
Journal:  J Biol Chem       Date:  2007-03-16       Impact factor: 5.157

Review 2.  Gestational restraint stress and the developing dopaminergic system: an overview.

Authors:  Carlos J Baier; María R Katunar; Ezequiela Adrover; María Eugenia Pallarés; Marta C Antonelli
Journal:  Neurotox Res       Date:  2012-01-04       Impact factor: 3.911

3.  Cyclin-dependent kinase 5 in the ventral tegmental area regulates depression-related behaviors.

Authors:  Peng Zhong; Xiaojie Liu; Zhen Zhang; Ying Hu; Sarah J Liu; Martha Lezama-Ruiz; Milan Joksimovic; Qing-song Liu
Journal:  J Neurosci       Date:  2014-04-30       Impact factor: 6.167

4.  Activation of glycogen synthase kinase-3 beta is required for hyperdopamine and D2 receptor-mediated inhibition of synaptic NMDA receptor function in the rat prefrontal cortex.

Authors:  Yan-Chun Li; Dong Xi; Joy Roman; Yue-Qiao Huang; Wen-Jun Gao
Journal:  J Neurosci       Date:  2009-12-09       Impact factor: 6.167

5.  Epidermal growth factor receptor as a molecular determinant of glioblastoma response to dopamine receptor D2 inhibitors.

Authors:  Yuyu He; Jie Li; Tomoyuki Koga; Jun Ma; Sanjay Dhawan; Yuta Suzuki; Frank Furnari; Varun V Prabhu; Joshua E Allen; Clark C Chen
Journal:  Neuro Oncol       Date:  2021-03-25       Impact factor: 12.300

6.  Activation of Dopamine D2 Receptor Suppresses Neuroinflammation Through αB-Crystalline by Inhibition of NF-κB Nuclear Translocation in Experimental ICH Mice Model.

Authors:  Yang Zhang; Yujie Chen; Jiang Wu; Anatol Manaenko; Peng Yang; Jiping Tang; Weiling Fu; John H Zhang
Journal:  Stroke       Date:  2015-08-06       Impact factor: 7.914

7.  NICEdrug.ch, a workflow for rational drug design and systems-level analysis of drug metabolism.

Authors:  Anush Chiappino-Pepe; Kiandokht Haddadi; Homa MohammadiPeyhani; Jasmin Hafner; Noushin Hadadi; Vassily Hatzimanikatis
Journal:  Elife       Date:  2021-08-03       Impact factor: 8.140

8.  Dopamine inhibits basal prolactin release in pituitary lactotrophs through pertussis toxin-sensitive and -insensitive signaling pathways.

Authors:  Arturo E Gonzalez-Iglesias; Takayo Murano; Shuo Li; Melanija Tomić; Stanko S Stojilkovic
Journal:  Endocrinology       Date:  2007-12-20       Impact factor: 4.736

9.  Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter.

Authors:  Valentina Ghisi; Amy J Ramsey; Bernard Masri; Raul R Gainetdinov; Marc G Caron; Ali Salahpour
Journal:  Cell Signal       Date:  2008-09-30       Impact factor: 4.315

Review 10.  Multiple roles of Gi/o protein-coupled receptors in control of action potential secretion coupling in pituitary lactotrophs.

Authors:  Stanko S Stojilkovic; Takayo Murano; Arturo E Gonzalez-Iglesias; Silvana A Andric; Marko A Popovic; Fredrick Van Goor; Melanija Tomić
Journal:  Ann N Y Acad Sci       Date:  2009-01       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.